# Chronic Obstructive Pulmonary Disease (COPD)

### Investigations

- `CBC` : ↑ RBCs
- `CXR`: Hyperinflation
- `CT`
- `ECG`: Right atrial and ventricular hypertrophy (cor pulmonale)
- `ABG`: ↓ PₐO₂ ± hypercapia
- `Spirometry` (FEV₁ <80% of predicted, FEV₁:FVC ratio <70%, ↑ TLC, ↑ RV, ↓ DLCO in emphysema)

### Treatment

- Smoking cessation
- Encourage exercise
- Diet advice ± supplements
- `Mucolytics`
- Screen for depression
- `Diuretics` if Edema
- Flu and pneumococcal `Vaccinations`
- Start by short-acting β₂-antagonist (`SABA`) or short-acting muscarinic antagonist (`SAMA`)
- If no optimal response but FEV₁ >50%

  - Use Long-acting β₂-antagonist (`LABA`) or Long-acting muscarinic antagonist (`LAMA`)
  - If on `LABA` and no optimal response move to `LABA + inhaled corticosteroid` (ICS)
  - If no optimal response or was on `LAMA` then move to `LAMA plus LABA/ICS` combination inhaler

- If no optimal response but FEV₁ <50%

  - use `LABA` plus inhaled corticosteroid (`ICS`) in combined inhaler or Long-acting muscarinic antagonist (`LAMA`)
  - If no optimal response move to `LAMA plus LABA/ICS` combination inhaler

- `Long-term O₂ therapy` if
- Clinically stable non-smokers with PₐO₂ <7.3kPa—despite maximal treatment. These values should be stable on two occasions >3wks apart.
- If PₐO₂ 7.3–8.0 and pulmonary hypertension (eg RVH; loud S2), or polycythaemia, or peripheral oedema, or nocturnal hypoxia
- O₂ can also be prescribed for terminally ill patients.
